Literature DB >> 17050899

FDA regulation of stem-cell-based therapies.

Dina Gould Halme1, David A Kessler.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17050899     DOI: 10.1056/NEJMhpr063086

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  113 in total

1.  Changes of the Functional Capacity of Mesenchymal Stem Cells due to Aging or Age-Associated Disease - Implications for Clinical Applications and Donor Recruitment.

Authors:  Günter Lepperdinger; Regina Brunauer; Robert Gassner; Angelika Jamnig; Frank Kloss; Gerhard Thomas Laschober
Journal:  Transfus Med Hemother       Date:  2008-07-17       Impact factor: 3.747

Review 2.  The potential of adipose stem cells in regenerative medicine.

Authors:  Bettina Lindroos; Riitta Suuronen; Susanna Miettinen
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 3.  Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds.

Authors:  Giovanni Marfia; Stefania Elena Navone; Clara Di Vito; Nicola Ughi; Silvia Tabano; Monica Miozzo; Carlo Tremolada; Gianni Bolla; Chiara Crotti; Francesca Ingegnoli; Paolo Rampini; Laura Riboni; Roberta Gualtierotti; Rolando Campanella
Journal:  Organogenesis       Date:  2015       Impact factor: 2.500

4.  Adipose-derived stem-cell-seeded non-cross-linked porcine acellular dermal matrix increases cellular infiltration, vascular infiltration, and mechanical strength of ventral hernia repairs.

Authors:  Tejaswi S Iyyanki; Lina W Dunne; Qixu Zhang; Justin Hubenak; Kristin C Turza; Charles E Butler
Journal:  Tissue Eng Part A       Date:  2014-10-02       Impact factor: 3.845

5.  Informed consent in embryonic stem cell research: are we following basic principles?

Authors:  Timothy Caulfield; Ubaka Ogbogu; Rosario M Isasi
Journal:  CMAJ       Date:  2007-06-05       Impact factor: 8.262

6.  The current status of islet transplantation and its perspectives.

Authors:  Naoya Kobayashi
Journal:  Rev Diabet Stud       Date:  2008-11-10

Review 7.  Cell-based therapy in ischemic stroke.

Authors:  David C Hess; Cesar V Borlongan
Journal:  Expert Rev Neurother       Date:  2008-08       Impact factor: 4.618

8.  Cell therapy: cGMP facilities and manufacturing.

Authors:  Raffaella Giancola; Tiziana Bonfini; Antonio Iacone
Journal:  Muscles Ligaments Tendons J       Date:  2012-10-16

9.  Regulatory issues for personalized pluripotent cells.

Authors:  Maureen L Condic; Mahendra Rao
Journal:  Stem Cells       Date:  2008-07-31       Impact factor: 6.277

10.  Synthetic alternatives to Matrigel.

Authors:  Elizabeth A Aisenbrey; William L Murphy
Journal:  Nat Rev Mater       Date:  2020-05-27       Impact factor: 66.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.